ConductScience.org, home

Paper36937127

Aldosterone Synthase Inhibitors and Dietary Interventions: A Combined Novel Approach for Prevention and Treatment of Cardiovascular Disease.

Awosika A and 4 others. Cureus, 2023. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Aldosterone Synthase Inhibitors and Dietary Interventions: A Combined Novel Approach for Prevention and Treatment of Cardiovascular Disease. Papers, record 36937127. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36937127

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Aldosterone Synthase Inhibitors and Dietary Interventions: A Combined Novel Approach for Prevention and Treatment of Cardiovascular Disease.
PubMed
Journal
Cureus
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
1.58
iCite
Revised in PubMed
2023-03-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Awosika AAyoola
2Khan AAnosh
3Adabanya UUzochukwu
4Omole AEAdekunle E
5Millis RMRichard M

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112821954Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials.J Hum Hypertens2003https://conductscience.org/library/papers/12821954PubMed
217309947Nongenomic actions of aldosterone on the renal tubule.Hypertension2007https://conductscience.org/library/papers/17309947PubMed
324732242Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality.BMJ Open2014https://conductscience.org/library/papers/24732242PubMed
435197862Aldosterone-Regulated Sodium Transport and Blood Pressure.Front Physiol2022https://conductscience.org/library/papers/35197862PubMed
52063193Blood pressure control--special role of the kidneys and body fluids.Science1991https://conductscience.org/library/papers/2063193PubMed
63416162Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group.BMJ1988https://conductscience.org/library/papers/3416162PubMed
725683946Efficacy and safety of LCI699 for hypertension: a meta-analysis of randomized controlled trials and systematic review.Eur Rev Med Pharmacol Sci2015https://conductscience.org/library/papers/25683946PubMed
824107737Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.J Hypertens2013https://conductscience.org/library/papers/24107737PubMed
923558163Effect of lower sodium intake on health: systematic review and meta-analyses.BMJ2013https://conductscience.org/library/papers/23558163PubMed
1025491597Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects.J Transl Med2014https://conductscience.org/library/papers/25491597PubMed
1131033166The Science of Salt: Updating the evidence on global estimates of salt intake.J Clin Hypertens (Greenwich)2019https://conductscience.org/library/papers/31033166PubMed
1222052934
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.
Circulation2011https://conductscience.org/library/papers/22052934PubMed
1329141784Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure.J Am Coll Cardiol2017https://conductscience.org/library/papers/29141784PubMed
1424851061The renin-angiotensin system and aging in the kidney.Korean J Intern Med2014https://conductscience.org/library/papers/24851061PubMed
1510338465Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis.Circulation1999https://conductscience.org/library/papers/10338465PubMed
1626240595Salt Sensitivity and Hypertension: A Paradigm Shift from Kidney Malfunction to Vascular Endothelial Dysfunction.Electrolyte Blood Press2015https://conductscience.org/library/papers/26240595PubMed
1736568122The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36568122PubMed
1829655877Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.Lancet Diabetes Endocrinol2018https://conductscience.org/library/papers/29655877PubMed
199582047Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis.JAMA1998https://conductscience.org/library/papers/9582047PubMed
2030968755How Do Kidneys Adapt to a Deficit or Loss in Nephron Number?Physiology (Bethesda)2019https://conductscience.org/library/papers/30968755PubMed

See all 62 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42260805Safety and efficacy of lorundrostat, an aldosterone synthase inhibitor, in patients with uncontrolled hypertension: A systematic review and meta-analysis.Medicine (Baltimore)2026https://conductscience.org/library/papers/42260805PubMed
41362679Efficacy and safety of selective aldosterone synthase inhibitors in uncontrolled hypertension: a systematic review and meta-analysis of randomized controlled trials.Clin Hypertens2025https://conductscience.org/library/papers/41362679PubMed
41251750Efficacy and safety of lorundrostat in uncontrolled hypertension: a meta-analysis.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41251750PubMed
40337581New Therapies for the Management of Chronic Kidney Disease.Cureus2025https://conductscience.org/library/papers/40337581PubMed
39857805Detection of Deaths Caused by Hyperkalemia.Biomedicines2025https://conductscience.org/library/papers/39857805PubMed
38872758Aldosterone synthase inhibitor "Baxdrostat" for resistant hypertension: A clinical approach or futuristic idea?Chronic Dis Transl Med2024https://conductscience.org/library/papers/38872758PubMed
38612843Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.Int J Mol Sci2024https://conductscience.org/library/papers/38612843PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36937127

GET https://conductscience.org/api/papers/v1/36937127/references?page=2